Advertisement.

AAVXF Projected Dividend Yield

Ord/Abivax SA ( OTCBB : AAVXF )

f Abivax is a biotech company engaged in inflammatory and viral diseases. As a clinical-stage biotech company, Co. uses its three platforms to discover drug candidates, two of which are being tested in various clinical trials for the treatment of inflammatory bowel disease, rheumatoid arthritis, HIV and liver cancer. The anti-inflammatory and antiviral drug candidates and immunotherapies developed by Co. come from three proprietary technology platforms: a modulation of RNA biogenesis platform, an Immune Stimulation? platform, and a Polyclonal Antibody platform.

20 YEAR PERFORMANCE RESULTS

AAVXF Dividend History Detail
AAVXF Dividend News
AAVXF Competitors News

# of Shares: 0

Closing Price: 11.05

Current Market Value: 0.00

Cost Basis: 0.00

Date Acquired:

Dividend Cash Flow
Year	Annual Dividend	Dividend Growth	# of Shares	Annual Dividend Income	Yield On Cost %
2014	0.00	0%	0	$ 0.00	0.00%
2015	0.00	0%	0	$ 0.00	0.00%
2016	0.00	0%	0	$ 0.00	0.00%
2017	0.00	0%	0	$ 0.00	0.00%
2018	0.00	0%	0	$ 0.00	0.00%
2019	0.00	0%	0	$ 0.00	0.00%
2020	0.00	0%	0	$ 0.00	0.00%
2021	0.00	0%	0	$ 0.00	0.00%
2022	0.00	0%	0	$ 0.00	0.00%
2023	0.00	0%	0	$ 0.00	0.00%
2024	0.00	0%	0	$ 0.00	0.00%
2025	0.00	0%	0	$ 0.00	0.00%
Using the current years Dividend Growth rate of 0% and projecting 0% forward the annual dividend income in 10/yrs would be $ 0.00 with a yield on cost % of 0.00%
Rolling Last 4 qtrs dividends total $ 0.00 and Previous last 4 qtrs dividends total $ 0.00
Dividend 1 Yr Growth = ( 0.00 – 0.00 ) × 100 = 0% (Click the Edit pencil if you want to modify the forward dividend growth rate projection) 0.00

Year	Declaration Date	Ex-Dividend Date	Record Date	Payable Date	Dividend $ Amount
Total:					0.0000